Table 8.
Comparative table of CsA AUC exposure values compliances within therapeutic ranges.
| Number of Subjects | 1–5 Years (CsA + MMF) |
1–5 Years (CsA) |
Number of Subjects | >5 Years (CsA + MMF) |
>5 Years (CsA) |
|
|---|---|---|---|---|---|---|
| 51 | 3 | 96 | 46 | |||
| Therapeutic range | <3.04 mg/h/L |
26 (51.0%) |
1 (33.3%) |
<2.69 mg/h/L |
34 (35.4%) |
13 (28.3%) |
| 3.05–3.75 mg/h/L |
15 (29.4%) |
2 (66.7%) |
2.70–2.98 mg/h/L |
20 (20.8%) |
11 (23.9%) |
|
| >3.76 mg/h/L |
10 (19.6%) |
- | >2.99 mg/h/L |
42 (43.8%) |
22 (47.8%) |
CsA—cyclosporine; MMF—mycophenolate mofetil.